N/a
-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
-April 15 2020: PT increase to 41, Making new ATH's
-April 16 2020: Wins $483 Million US Government Award To Develop Coronavirus Vaccine
-May 01 2020: Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Modernas Vaccine (mRNA-1273)
-May 06 2020: Weak earnings / lags estimates, FDA approves phase 2 of COVID-19 vaccine
-Jun 03 2020: MRNA in top 5 pick for vaccine candidate
-SPY pattern: Runner
-Intraday pattern: Afternoon Runner
-Levels: 63.5 - 64, 65, 66, 67
Strategy: FT-15 long of 63.5 level
Confluence: Half $, Gap Fill
Strike Zone: 64 - 63.5
Sizing (lots): 4 (can only use 2 due to margin requirements)
Risk (stop / Rs): Hold below 63.5
Saw it bounce prematurely from 64.20's so I only had a starter the second time around when it bounced. Trade was good but not enough size to matter.
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2020-06-15 09:46:14 | MRNA | buy | $63.900 | long |
2020-06-15 09:51:21 | MRNA | sell | $64.470 | long |
2020-06-15 09:54:31 | MRNA | sell | $64.620 | long |
2020-06-15 09:54:47 | MRNA | sell | $64.610 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!